This is one reason people with obesity or metabolic syndrome often also deal with elevated CRP, rising triglycerides, worsening glucose control, joint discomfort, and fatigue
Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: a post-hoc analysis of a 52-week randomised trial
7 Thats why self-adjusting your dose is not recommendedtoo much too soon can lead to unnecessary side effects, while too little may not provide the desired results
Webinars & White Papers From Alzheimers disease research to the real-world setting: Connecting scientific progress with system readiness In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space
The diagrams in a , e and i were created using BioRender
Sonophoresis: Uses ultrasound waves to temporarily disrupt the skin barrier